Compound News and Research

RSS

Medical Research Council funds research to look at cannabis based medicines in multiple sclerosis treatment

A trial to determine whether cannabis-based medicines can reduce disability in patients with multiple sclerosis (MS) has been funded by the Medical Research Council (MRC).

24 May 2005

Activation of thermoreceptors mediates raw garlic's burning pungency

The worldwide popularity of garlic as a food ingredient and its therapeutic stature in folklore both stem in part from the distinctive pungency associated with its raw, uncooked state.

23 May 2005

Grapefruit extract may help heal stomach ulcers

A new study from Poland has found that grapefruit seed extract, which contains powerful antioxidants, may help heal stomach ulcers.

18 May 2005

Older adults with insomnia report falling asleep faster with Ramelteon

Results from a Phase 3 clinical study presented at the 2005 Annual Scientific Meeting of the American Geriatrics Society showed that bedtime administration of ramelteon, an investigational compound currently under review for the treatment of insomnia, significantly reduced time to fall asleep in older adults with chronic insomnia. Additionally, no rebound insomnia or withdrawal effects were observed.

18 May 2005

Advanced breast cancer drug appears effective on multiple targets

An experimental breast cancer drug that simultaneously attacks five tumor targets has halted progression of the disease in a clinical trial for patients with advanced disease.

18 May 2005

Grapefruit have strong antioxidant properties that can have healing effects on stomach ulcers

Extracts of the popular diet item grapefruit have strong antioxidant properties that can have healing effects on stomach ulcers, according to a new study presented today at Digestive Disease Week 2005 (DDW).

17 May 2005

Pills made from the plant kudzu may help binge drinkers lose the urge

Researchers have found that drinkers seemed to lose the urge to binge-drink when they took pills made from the plant kudzu. Experts say the groundbreaking discovery may lead to a way to attack the rising binge-drinking problem which is especially prevalent among young people.

17 May 2005

Antibody combined with cancer drug shows promise against breast tumors

An antibody that targets the blood vessels nourishing tumors significantly reduced breast cancer formation and growth in mice when combined with a current cancer drug, according to researchers at UT Southwestern Medical Center.

16 May 2005

More health benefits from green tea

Green tea appears to protect against cancer by affecting a "promiscuous" protein that pharmaceutical experts are already targeting in an effort to develop a new drug to stop the disease, scientists at the University of Rochester Medical Center have found.

16 May 2005

Two-sided coating could breathe life into medical implants

By mimicking an adhesive protein secreted by mussels and a polymer that repels cells and proteins, researchers at Northwestern University have designed a versatile new two-sided coating that could breathe life into medical implants.

15 May 2005

Cataract treatment in the blink of an eye

Researchers at the University of Canterbury, New Zealand are pioneering the development of an eye drop to halt the development of cataracts.

10 May 2005

Swedish study suggests gay men's brains differ from heterosexual men's

Researchers in Sweden have found that a compound taken from male sweat stimulates the brains of gay men and straight women but not heterosexual men, which raises the possibility that homosexual brains are different.

9 May 2005

Nephrogenic Syndrome of Inappropriate Antidiuresis - a new genetic disease

Two infant boys whose bodies were overloaded with excess fluid have led UCSF pediatricians to the discovery of a new genetic disease. In the process, they have discovered a rare type of mutation where different substitutions in a single amino acid cause two different, opposite genetic disorders.

4 May 2005

Food fried in vegetable oil contains a highly toxic compound - HNE (4-hydroxy-trans-2-nonenal)

University of Minnesota researchers A. Saari Csallany, a professor of food chemistry and nutritional biochemistry, and graduate student Christine Seppanen have shown that when highly unsaturated vegetable oils are heated at frying temperature (365 F) for extended periods--or even for half an hour--a highly toxic compound, HNE (4-hydroxy-trans-2-nonenal) forms in the oil.

2 May 2005

New drug may help treat certain forms of leukemia

A new experimental drug may be effective against a certain form of leukemia resistant to current treatments, research at UT Southwestern Medical Center shows.

2 May 2005

Little known enzyme ACAT2 appears to be a factor in cardiovascular disease

New research suggests that a little-studied enzyme ACAT2, may play a major role in cardiovascular disease because it alters the molecular structure of cholesterol.

2 May 2005

Generex begins testing new vaccine for breast cancer patients

Generex Biotechnology Corporation announced today that the first patients had received a novel therapeutic vaccine developed by its wholly owned subsidiary, Antigen Express as part of the Company's Phase I Trial. The Trial will include between 16 and 24 patients.

28 Apr 2005

National clinical trial examines new option for kidney cancer patients

The trial, which opened last September, offers research subjects who qualify a new, targeted therapy in addition to standard immune therapy. The drug combination is being studied in a national Phase II clinical trial led by OHSU Cancer Institute researcher Christopher Ryan, M.D., through the Southwest Oncology Group, one of the largest clinical trial cooperative groups in the United States.

27 Apr 2005

Smad7 protein levels may predict prostate cancer therapy response

Levels of the Smad7 protein may predict therapeutic response in patients with prostate cancer according to research published by investigators at the Uppsala Branch of the Ludwig Institute for Cancer Research (LICR).

23 Apr 2005

Exposure to air pollutants increases the risk of fatal myocardial infarction

Cardiovascular diseases are the most common cause of death in Sweden and other Western European countries. Known risk factors include age, gender, hereditariness, smoking, hypertension and high blood lipid levels.

22 Apr 2005